During the past decade, PRACS Institute, Ltd. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "PRACS Institute, Ltd." are "Healthy" (13 trials). Many other conditions were trialed in "PRACS Institute, Ltd." in a lesser frequency.

Most popular intervention types in "PRACS Institute, Ltd." are "Drug" (13 trials). Other intervention types were less common.

The name of intervention was led by "5 mg/500 mg Glipizide Metformin Hydrochloride Tablets" (2 trials), "5 mg/500 mg METAGLIP™ Tablets" (2 trials), "Alprazolam Extended-Release 3 mg Tablets" (2 trials), "Aricept®" (2 trials) and "Cefdinir Capsules 300 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "PRACS Institute, Ltd." are 13 trials for "All" genders.

Currently, there are NaN active trials in "PRACS Institute, Ltd.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in PRACS Institute, Ltd., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PRACS Institute, Ltd., 13 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".